Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,204 total articles
Microsoft pulled back into the low-$400s and the dip looks buyable for a long-term trade. The company still delivers high return on equity, strong free cash flow and durable cloud/AI revenue streams. My plan: enter near current levels, limit downside with a firm stop, and target a recovery toward the 50-day SMA and the next resistance band over the…
Energy Transfer (ET) trades cheap on EV/EBITDA and P/E, yields ~7.3%, and sits squarely in the path of rising natural gas demand driven by winter weather and incremental load from AI data centers. This trade idea lays out an entry at $18.12, a stop at $17.00 and a target of $20.50 over a mid-term (45 trading days) horizon with clear catalysts and r…
East West Bancorp (EWBC) remains a quality regional bank with healthy returns and a diversified franchise. The stock sits near its 52-week high with a mid-teens return-on-equity and a reasonable P/E; that makes EWBC a buy on weakness rather than a bargain. Trade plan: enter on a modest pullback, limit downside with a defined stop, and target re-rat…
Adobe has been driven to multi-year lows amid sector rotation and AI-related fear. Fundamentals remain healthy - $108.8B market cap, strong free cash flow of $9.85B and ROE north of 60% - while technicals scream oversold (RSI ~25). This trade targets a measured bounce to the 50-day moving average with a clear entry, stop and target and a mid-term (…
AppLovin’s shares have been hit hard by headlines about CloudX and new AI tools from big tech. Fundamentals still show substantial free cash flow, strong ROA/ROE, and meaningful upside to the 52-week high if growth stabilizes. I outline an actionable long trade with entry, stop and target, plus the key catalysts and risks that would change my view.
Krystal Biotech's FDA RMAT designation for KB707 and robust VYJUVEK revenue put the stock in a favorable spot for a tactical long. The balance sheet and free cash flow provide runway through 2026, while an expected KB707 program update in the second half of 2026 is a clear binary catalyst. Valuation is rich relative to sales but the near-term clini…
AGQ, a 2x daily leveraged silver futures ETF, has pulled back sharply from January highs and now trades at $147.26. The fund’s 52-week range ($31.88 to $431.47) and heavy volume profile make this a viable tactical buy-the-dip candidate for traders willing to accept elevated volatility, decay risk and the possibility of extended downside. This trade…
Deutsche Bank is trading at a multi-year low valuation gap relative to its rebound in earnings and an improving macro backdrop. With a market cap near $70.9B, a P/E of 9.5 and P/B under 1, the stock is positioned for a tactical re-rating as investors rotate back into European banks. We present a mid-term trade idea with concrete entry, target and s…
Encompass Health (EHC) offers an asymmetric setup: reliable free cash flow, double-digit ROE and modest valuation multiples versus its operational reach. Recent headlines around patient safety created an entry point. This trade aims to capture restoration of investor confidence while respecting litigation and reimbursement risks.
Equinor combines a near-4% dividend, ongoing buybacks and meaningful North Sea license wins with a conservative valuation for a diversified integrated oil and renewables player. We like EQNR as a long-term trade to capture yield, buyback-driven EPS support and upside from stable upstream cash flow.
Meta is executing on ad recovery and AI-first infrastructure spending while maintaining strong cash flow and returns. The fundamental setup supports a tactical long trade: enter near current levels, stop decisively below $640, and target upside into the $740s-$750s over a mid-term horizon as AI catalysts and ad-market tailwinds materialize.
Playboy (PLBY) just closed a material strategic transaction for its China business that should deliver meaningful cash proceeds and address leverage. The stock has already reacted but remains a high-upside, event-driven trade if you size it and manage risk. This plan outlines a mid-term swing entry, stop, and target, with the rationale anchored to …
ORIX (IX) looks actionable after a sharp run: management is pushing buybacks and earnings timing is coming forward, creating a near-term earnings and capital-return story. The company trades at a market cap of about $40.7B, a PE of ~12.2 and PB of ~1.29, and still offers a 2.1% dividend. We're recommending a long position with an entry at $35.03, a…
Ferrari ripped higher after Q4 results, reminding investors its pricing and scarcity model still commands a premium. With a $92B market cap, a fresh buyback program and technical momentum, the risk/reward favors a mid-term long on a measured pullback. This trade idea lays out entry, stop, targets and the key risks to monitor.
Coherent's compound-semiconductor platforms and recent beat-guidance cadence suggest the company can capture outsized demand for high-speed optical modules. I like a mid-term long trade sized for alpha capture while respecting valuation and execution risks.
Coherent (COHR) has obvious risks: rich valuation, negative free cash flow, and cyclical end markets. Those risks are priced into the stock today, but accelerating demand for high-speed optical connectivity in AI/data centers and recent beat-and-raise results create an asymmetric trade. This plan lays out an entry at $231.00, a hard stop at $205.00…
Novo Nordisk plunged after guidance for 2026 showed a 5-13% sales and earnings decline amid lower U.S. GLP-1 pricing. Yet the stock has stabilized near $50, supported by strong product adoption, a sensible valuation (PE ~14), and a legal/regulatory backdrop that is tightening around copycat suppliers. This trade targets a recovery into the mid-$50s…
RTX is sitting on a deep backlog and accelerating service wins. Management’s digital transformation — expanded GTF MRO, analytics-driven spare-parts optimization, and longer service agreements at Collins and Pratt & Whitney — can act as a margin multiplier, justifying a re-rating from the mid-30s P/E range toward the mid-20s EV/EBITDA peers trade a…
Kroger shares have jumped on news of a new CEO appointment and recent operational wins. The fundamentals show a large, cash-generating retailer with reasonable EV/EBITDA but high leverage and a stretched valuation on earnings. This trade idea lays out a mid-term swing trade to capture a potential re-rating while managing downside with a strict stop…
Amazon pulled back into the low $200s and is trading near oversold technicals while valuation is reasonable for a company with AWS and advertising cash generation. I’m taking a long-biased, size-controlled position at current levels with a clear stop and a $260 target for the next several months. The trade rests on a mean-reversion bounce, continue…
Amazon's share-price weakness has priced in near-term uncertainty, but fundamentals - high ROE, durable AWS margins, low leverage - and an oversold technical setup support a long trade. We upgrade to Buy and outline an actionable entry at $208.35, a $260 target and a $190 stop for a long-term (180 trading days) swing.
ServiceNow has been punished in the recent software selloff, but its recurring revenue base, growing AI monetization (NOW Assist), strong free cash flow, and an oversold technical backdrop create a favorable asymmetric trade. This is a mid-term swing idea: enter $106.42, stop $95, target $150 over ~45 trading days.
Natural Grocers (NGVC) trades at single-digit EV/EBITDA and a ~12x P/E with steady free cash flow and a small dividend. Recent pullback has left the stock near a five-month low; technical signals and improving short-interest dynamics suggest a bounce into nearby resistance. This is a mid-term rebound trade for disciplined bottom-fishers.
Switch 2's unit momentum, upcoming franchise releases and ancillary media (Super Mario Galaxy movie) set a classic Nintendo rebound setup. Fundamentals and brand strength argue for a mid-term long position after this pullback; price action and technicals demand a tight stop. Entry, target and stop provided for a clear trade plan.
Addus HomeCare is set up to convert steady demand in personal and home health care into above-consensus organic volume growth. The stock trades at a reasonable P/E and EV/EBITDA, with free cash flow supporting a measured upside if volumes and mix improve. This trade idea outlines an entry, stop and target for a mid-term swing (45 trading days) whil…
